Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Consolidated Net Income (2022 - 2024)

Opus Genetics (IRD) has disclosed Consolidated Net Income for 6 consecutive years, with -$40.4 million as the latest value for Q4 2021.

  • On a quarterly basis, Consolidated Net Income changed N/A to -$40.4 million in Q4 2021 year-over-year; TTM through Sep 2022 was -$40.4 million, a 2019.27% decrease, with the full-year FY2022 number at $17.9 million, up 131.55% from a year prior.
  • Consolidated Net Income was -$40.4 million for Q4 2021 at Opus Genetics, down from -$1.9 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of -$40.4 million in Q4 2021 to a low of -$40.4 million in Q4 2021.